NCT02003170

Brief Summary

The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
576

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

November 25, 2013

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 6, 2013

Completed
10.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 6, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 6, 2024

Completed
Last Updated

July 8, 2024

Status Verified

July 1, 2024

Enrollment Period

12.1 years

First QC Date

November 25, 2013

Last Update Submit

July 5, 2024

Conditions

Keywords

AutismAutism Spectrum Disorder (ASD)Pervasive Developmental Disorder (PDD)Developmental delaysGenetic disorderMitochondrial disorder

Outcome Measures

Primary Outcomes (1)

  • Medical abnormalities associated with specific neurodevelopmental disorders

    It is unknown if a specific set of biological abnormalities contribute to the formation of many types of neurodevelopmental disorders. The study is intended to identify the relationship between biological abnormalities and neurodevelopmental disorders

    up to 7 years

Secondary Outcomes (2)

  • Biomarkers associated with neurodevelopmental disorders

    up to 7 years

  • Treatments associated with neurodevelopmental disorders

    up to 7 years

Study Arms (1)

Neurodevelopmental Disorders

Children who present to various Arkansas Children's Hospital clinics for standard care related to neurodevelopmental disorders.

Eligibility Criteria

Age0 Months - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Children who present to various Arkansas Children's Hospital Outpatient clinics for standard care related to neurodevelopmental disorders.

You may qualify if:

  • Neurodevelopmental delays
  • Clinical visit at an Arkansas Children's Hospital Outpatient clinic

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arkansas Children's Hospital Research Institute

Little Rock, Arkansas, 72205, United States

Location

Related Publications (1)

  • Frye RE, Lionnard L, Singh I, Karim MA, Chajra H, Frechet M, Kissa K, Racine V, Ammanamanchi A, McCarty PJ, Delhey L, Tippett M, Rose S, Aouacheria A. Mitochondrial morphology is associated with respiratory chain uncoupling in autism spectrum disorder. Transl Psychiatry. 2021 Oct 13;11(1):527. doi: 10.1038/s41398-021-01647-6.

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Blood, urine, cerebrospinal fluid, muscle, and skin samples may be retained.

MeSH Terms

Conditions

Neurodevelopmental DisordersAutistic DisorderAutism Spectrum DisorderChild Development Disorders, PervasiveGenetic Diseases, InbornMitochondrial Diseases

Condition Hierarchy (Ancestors)

Mental DisordersCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Shannon Rose, PhD.

    Arkansas Children's Hospital Research Instisute; UAMS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2013

First Posted

December 6, 2013

Study Start

May 1, 2012

Primary Completion

June 6, 2024

Study Completion

June 6, 2024

Last Updated

July 8, 2024

Record last verified: 2024-07

Locations